Overview

Medicxi is a European investment firm focused on the life sciences sector, established in 2016 by the former Index Ventures life sciences team. The firm invests across the full drug development continuum, from discovery stage to pivotal studies and registration, with a mission to bring novel therapies to patients in need.

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.